Published in
Elsevier, Ophthalmology, 12(126), p. e95-e96, 2019
DOI: 10.1016/j.ophtha.2019.08.017
Links
Tools
Re: Dugel et al: HAWK and HARRIER: phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration (Ophthalmology. 2019 Apr 12 [Epub ahead of print])
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 